Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-1.94
↓ 129% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-0.85
Historical baseline
PeriodValueYoY Change
TTM-1.94+3.0%
2024-2.00-22.7%
2023-1.63-17.3%
2022-1.39-201.5%
20211.37+1153.8%
2020-0.13+18.8%
2019-0.16+82.2%
2018-0.90-